ISRCTN26727615已完成不适用
MRC ALL 97 - UK national lymphoblastic leukaemia (ALL) trial
Medical Research Council (MRC) (UK)0 个研究点目标入组 1,800 人开始时间: 2000年10月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Open to all children with ALL except those in 'Exclusions'
排除标准
- •1. Patients under 1 year or over 18 years,
- •2. B-ALL, Ph positivity, near haploidy in blasts or rearrangements involving the MLL gene on 11q23 and
- •3. High risk by Oxford Hazard Score (based on a function of age, gender and diagnostic leucocyte count)
研究者
相似试验
已完成
不适用
Medical Research Council Acute Lymphoblastic Leukaemia Trial in Children UKALL R1eukaemia (acute)CancerLeukaemiaISRCTN13327255Medical Research Council (MRC) (UK)256
进行中（未招募）
2 期
A study for patients with newly diagnosed Chronic Phase Myeloid Leukaemia evaluating the drug Asciminib.ACTRN12620000851965Australiasian Leukaemia and Lymphoma Group101
招募中
不适用
Australasian Leukaemia and Lymphoma Group National Blood Cancer RegistrySuspected or Known or Diagnosed Blood CancerCancer - Leukaemia - Acute leukaemiaPublic Health - Health service researchCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphomaACTRN12612000337875Australasian Leukaemia and Lymphoma Group2,000
已完成
不适用
KALL R2 - Acute Lymphoblastic Leukaemia trialAcute Lymphoblastic LeukaemiaCancerISRCTN95257778Medical Research Council (MRC) (UK)200
已完成
不适用
Medical Research Council Adult Acute Lymphoblastic Leukaemia Trial UKALL XAeukaemia (acute)Lymphoid leukaemiaCancerISRCTN35362654Medical Research Council (MRC) (UK)618